| From recipe to dinner: business model portfolios in the European biopharmaceutical industry V Sabatier, V Mangematin, T Rousselle Long Range Planning 43 (2-3), 431-447, 2010 | 454 | 2010 |
| When technological discontinuities and disruptive business models challenge dominant industry logics: Insights from the drugs industry V Sabatier, A Craig-Kennard, V Mangematin Technological Forecasting and Social Change 79 (5), 949-962, 2012 | 280 | 2012 |
| Learning, signaling, and convincing: The role of experimentation in the business modeling process N Bojovic, C Genet, V Sabatier Long Range Planning 51 (1), 141-157, 2018 | 90 | 2018 |
| Articulating growth and cultural innovation in art museums: The Louvre's business model revision E Coblence, V Sabatier International Studies of Management & Organization 44 (4), 9-25, 2014 | 62 | 2014 |
| Becoming through doing: How experimental spaces enable organizational identity work N Bojovic, V Sabatier, E Coblence Strategic Organization 18 (1), 20-49, 2020 | 50 | 2020 |
| Social business model design and implementation in developing countries: Learning from an affordable medicine developed in Burkina Faso V Sabatier, I Medah, P Augsdorfer, A Maduekwe Journal of Management Development 36 (1), 48-57, 2017 | 50 | 2017 |
| Orchestrating networks in the biopharmaceutical industry: small hub firms can do it V Sabatier, V Mangematin, T Rousselle Production Planning and Control 21 (2), 218-228, 2010 | 44 | 2010 |
| Strategic renewal in times of environmental scarcity: The mediating role of technology in business model evolution S Al Humaidan, V Sabatier Journal of Organizational Change Management 30 (1), 106-120, 2017 | 35 | 2017 |
| The role of costs in business model design for early-stage technology startups RG Chammassian, V Sabatier Technological Forecasting and Social Change 157, 120090, 2020 | 34 | 2020 |
| Psychological, social and technical factors influencing electronic medical records systems adoption by United States physicians: a systematic model R El-Yafouri, L Klieb, V Sabatier Health Research Policy and Systems 20 (1), 48, 2022 | 13 | 2022 |
| Rethinking business models for innovation V Chanal, S Akselsen, S Blanco, ML Caron-Fasan, B Cartoux, ... Rethinking business models for innovation, 154, 2011 | 11 | 2011 |
| What innovative business models can be triggered by precision medicine? Analogical reasoning from the magazine industry N Bojovic, V Sabatier, S Rouault Innovation and Entrepreneurship in Health, 81-94, 2015 | 8 | 2015 |
| Discontinuités téchnologiques et business models: analyse des mécanismes de transformation de l'industrie du médicament V Sabatier Université de Grenoble, 2011 | 6 | 2011 |
| From business model to business model portfolio in the European biopharmaceutical industry V Sabatier, V Mangematin, T Rouselle HAL Working Papers, 2009 | 5 | 2009 |
| The impact of office-related metrics on meeting physician expectations from Electronic Medical Record systems R El-Yafouri, L Klieb, V Sabatier Healthcare Analytics 4, 100208, 2023 | 4 | 2023 |
| Going virtual in the European Biopharmaceutical Industry: Conductors and Oxpeckers make it V Sabatier, V Mangematin, T Rousselle Working Conference on Virtual Enterprises, 93-104, 2008 | 1 | 2008 |
| Psychological, Social and Technical Factors Influencing Electronic Medical Records Systems Adoption by US Physicians: A Systematic Model R El-Yafouri, L Klieb, V Sabatier | | 2020 |
| How does one encourage the production of vaccines in Developing Countries? S Meniri, P Legeard, V Sabatier | | 2013 |
| How to encourage the production of vaccines for developing countries? S Meniri, P Legeard, V Sabatier BIOFUTUR, 54-57, 2013 | | 2013 |
| Innovation Buy-In at Schneider Electric: The KIBIS Method S Blanco, V Sabatier, C Genet, B Cartoux Discontinuous Innovation: Learning To Manage The Unexpected 22, 289, 2013 | | 2013 |
